IO Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IO Biotech and other ETFs, options, and stocks.About IOBT
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms.
CEOMai-Britt Zocca
CEOMai-Britt Zocca
Employees80
Employees80
HeadquartersCopenhagen, North Denmark
HeadquartersCopenhagen, North Denmark
Founded2014
Founded2014
Employees80
Employees80
IOBT Key Statistics
Market cap64.56M
Market cap64.56M
Price-Earnings ratio-0.66
Price-Earnings ratio-0.66
Dividend yield—
Dividend yield—
Average volume96.77K
Average volume96.77K
High today$1.03
High today$1.03
Low today$0.97
Low today$0.97
Open price$1.02
Open price$1.02
Volume86.12K
Volume86.12K
52 Week high$1.73
52 Week high$1.73
52 Week low$0.66
52 Week low$0.66
People also own
Based on the portfolios of people who own IOBT. This list is generated using Robinhood data, and it’s not a recommendation.